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SUMMARY	  
MicroRNAs	   are	   important	   regulators	   of	   gene	   expression	   and	   associated	   with	   stress-­‐related	  
psychiatric	   disorders.	   Here,	  we	   report	   that	   exposing	  mice	   to	   chronic	   stress	   led	   to	   a	   specific	  
increase	  in	  microRNA-­‐15a	  levels	  in	  the	  amygdala-­‐Ago2	  complex,	  and	  a	  concomitant	  reduction	  
in	   the	   levels	  of	   its	  predicted	   target,	  FKBP51,	  which	   is	   implicated	   in	   stress-­‐related	  psychiatric	  
disorders.	  	  Reciprocally,	  mice	  expressing	  reduced	  levels	  of	  amygdalar	  microRNA-­‐15a	  following	  
exposure	   to	   chronic	   stress	   exhibited	   increased	   anxiety-­‐like	   behaviors.	   In	   humans,	  
pharmacological	   activation	   of	   the	   glucocorticoid	   receptor	   as	   well	   as	   exposure	   to	   childhood	  
trauma	   was	   associated	   with	   increased	   microRNA-­‐15a	   levels	   in	   peripheral	   blood.	   Taken	  
together,	  our	  results	  support	  an	  important	  role	  for	  microRNA-­‐15a	  in	  stress	  adaptation	  and	  the	  
pathogenesis	  of	  stress-­‐related	  psychopathologies.	  	  
HIGHLIGHTS	  	  
• MiR-­‐15a	  levels	  are	  elevated	  in	  the	  amygdala-­‐Ago2	  complex	  following	  chronic	  stress	  	  
• MiR-­‐15a	  targets	  FKBP51	  and	  affects	  behavioral	  responses	  to	  stressful	  challenges	  	  
• MiR-­‐15a	  is	  elevated	  in	  peripheral	  human	  blood	  following	  dexamethasone	  exposure	  
• MiR-­‐15a	  is	  elevated	  in	  peripheral	  human	  blood	  of	  patients	  exposed	  to	  childhood	  trauma	  
eTOC	  BLURB	  
Volk	   et	   al.	   reveal	   an	   important	   role	   for	   microRNA-­‐15a	   in	   coping	   with	   chronic	   stress,	   with	  
amygdala-­‐specific	  manipulation	  affecting	  behavioral	  responses	  to	  stressful	  challenge.	  Individuals	  
exposed	   to	   childhood	   trauma	   exhibit	   increased	   levels	   of	   miR-­‐15a	   in	   their	   peripheral	   blood	  
suggesting	  a	  novel	  target	  for	  the	  treatment	  of	  stress-­‐related	  psychopathologies.	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INTRODUCTION	  
Recent	  studies	  have	  linked	  microRNA	  (miRNA)	  expression	  or	  biogenesis	  dysregulation	  to	  various	  
psychiatric	  disorders	  including	  anxiety	  and	  depression	  (Dias	  et	  al.,	  2014b;	  Issler	  and	  Chen,	  2015;	  
Issler	  et	  al.,	  2014;	  Lopez	  et	  al.,	  2014;	  O'Connor	  et	  al.,	  2012;	  Volk	  et	  al.,	  2014)	  .	  However,	  changes	  
in	  miRNA	  expression	  levels	  do	  not	  necessarily	  reflect	  their	  immediate	  activity;	  it	  is	  only	  when	  a	  
specific	  miRNA,	   in	   the	   canonical	   pathway,	   has	  matured	   and	   been	   incorporated	   into	   the	   RNA-­‐
induced	   silencing	   complex	   (RISC)	   in	   the	   presence	   of	   argonaute	   RISC	   catalytic	   component	   2	  
(Ago2)	   that	   it	   becomes	   truly	   active	   (Meister	  et	   al.,	   2004)	   as	   a	   result	  of	   its	   association	  with	   its	  
target	  mRNA.	  
The	  amygdala	  plays	  a	  pivotal	  role	  in	  regulating	  the	  behavioral	  responses	  to	  stressful	  challenges	  
(Dunsmoor	   and	   Paz,	   2015;	   Duvarci	   and	   Pare,	   2014;	   Johansen	   et	   al.,	   2011;	   Luthi	   and	   Luscher,	  
2014;	  Maren	  and	  Holmes,	  2015).	  Recently,	  regulation	  of	  some	  amygdalar	  functions	  and	  stress-­‐
related	   behaviors	   has	   been	   attributed	   to	   miRNAs.	   MiR-­‐34c	   is	   involved	   in	   regulating	   stress-­‐
induced	  anxiety	  (Haramati	  et	  al.,	  2011)	  and	  miR-­‐34a	   in	  fear	  memory	  consolidation	  (Dias	  et	  al.,	  
2014).	  Furthermore,	  miR-­‐19b	  plays	  an	  important	  role	  in	  memory	  consolidation	  following	  stress	  
by	  regulating	  the	  adrenergic	  receptor	  beta	  1	  (	  Volk	  et	  al.,	  2014).	  	  	  
In	  this	  study,	  we	  investigated	  Ago2-­‐associated	  miRNAs	  and	  transcripts	  in	  the	  amygdala	  of	  mice	  
subjected	   to	   a	   chronic	   social	   defeat	   stress.	   This	   chronic	   social	   stress	   paradigm	   consists	   of	   10	  
consecutive	  days	  of	  short	  physical	  encounters	  between	  a	  C57BL/6	  mouse	  and	  an	  aggressive	  ICR	  
(CD1)	  mouse	   (Golden	   et	   al.,	   2011;	   Krishnan	   et	   al.,	   2007).	   The	   repeated	   exposure	   to	   stress	   is	  
considered	  a	  model	   for	   the	   induction	  of	   chronic	   stress	   (Elliott	   et	   al.,	   2010;	   Elliott	   et	   al.,	   2016;	  
Issler	  et	  al.,	  2014),	  as	  well	  as	  depression-­‐like	  behavior	  (Hollis	  and	  Kabbaj,	  2014;	  Malatynska	  and	  
Knapp,	  2005)	   in	  mice.	   	  Molecular	  analysis	  and	  behavioral	   studies	  demonstrate	   that	  miR-­‐15a	   is	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recruited	  to	  the	  Ago2	  complex	  following	  chronic	  stress	  and	  is	  an	  essential	  regulator	  of	  an	  intact	  
behavioral	  response	  to	  chronic	  stress.	  	  
	  
RESULTS	  
MiR-­‐15a	  and	  FKBP51	  mRNA	  are	  associated	  with	  Ago2	  in	  the	  amygdala	  following	  chronic	  stress	  
To	   identify	   novel	   miRNAs	   that	   are	   involved	   in	   the	   regulation	   of	   the	   behavioral	   response	   to	  
chronically	   stressful	   challenges,	   we	   immunoprecipitated	   the	   Ago2	   complex	   in	   tissue	   obtained	  
from	   the	   amygdala	   of	  mice,	   8	   days	   after	   completion	   of	   the	   chronic	   social	   defeat	   stress.	  Mice	  
were	  subjected	  to	  the	  chronic	  social	  defeat	  stress	  paradigm	  for	  10	  consecutive	  days	  (Figure	  1A)	  
following	   which	   they	   were	   subjected	   to	   a	   social	   avoidance	   test	   to	   categorize	   them	   as	   being	  
either	  “Susceptible”	  or	  “Resilient”	  to	  the	  chronic	  social	  defeat	  stress	  (Figure	  1B).	  The	  RNA	  from	  
the	  Ago2	  complex	  of	  3	  groups:	  Susceptible,	  Resilient	  and	  Control,	  was	  extracted	  and	  analyzed	  in	  
parallel	  using	  2	  distinct	  microarray	  platforms;	  a	  miRNA	  and	  a	  mRNA	  expression	  array	  (Figure	  1C).	  
Initially,	  we	  hypothesized	  that	  we	  would	  observe	  changes	  in	  the	  miRNA	  population	  of	  the	  Ago2	  
complex	  in	  the	  amygdala	  not	  only	  between	  stressed	  and	  control	  mice	  but	  between	  Susceptible	  
and	  Resilient	  mice.	  However,	   our	   analysis	   revealed	   that	   no	   significant	   changes	  were	  detected	  
between	  the	  Susceptible	  and	  Resilient	  mice.	  For	  this	  reason,	  we	  combined	  the	  2	  groups	  of	  mice	  
into	  1	   that	   is	   referred	   to	   in	   the	   text	  as	   ‘social	  defeat’.	  Analysis	  of	   the	  miRNA	  array	   revealed	  4	  
miRNAs	   that	   were	   upregulated	   and	   10	   that	   were	   downregulated	   (Figure	   1D,	   Figure	   S1A).	   A	  
parallel	   analysis	   on	   the	   gene	   array	   revealed	   a	   small	   number	   of	   mRNAs	   that	   were	   either	  
upregulated	  or	  down	  regulated	   in	   the	  Ago2	  complex	   immunoprecipitation	   (IP)	   following	  social	  
defeat	   (Figure	  S1B).	  When	  we	  analyzed	   the	  mRNAs	   that	  were	  changed	   following	   social	  defeat	  
we	   focused	  on	   stress	   associated	   genes	   that	  were	  previously	  described	   to	  be	  expressed	   in	   the	  
amygdala.	   This	   is	   the	   reason	  we	   focused	  on	   FK506	  binding	   protein	   51	   (FKBP51)	   and	  miR-­‐15a.	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FKBP51	   has	   been	   previously	   linked	   to	   the	   pathogenesis	   of	   posttraumatic	   stress	   disorder	   and	  
depression	  (Binder	  et	  al.,	  2008a;	  Klengel	  et	  al.,	  2013;	  Lekman	  et	  al.,	  2008;	  Zannas	  et	  al.,	  2016).	  
MiR-­‐15a	  levels	  were	  raised	  1.8	  fold	  (p=0.0002)	  in	  the	  array	  following	  exposure	  to	  chronic	  stress	  
(Figure	  1E).	   	   Interestingly,	  a	  parallel	   increase	   in	  FKBP51	  mRNA	  (p=0.001),	  a	  predicted	  target	  of	  
miR-­‐15a,	  was	  observed	   in	   the	  Ago2	   complex	   (Figure	  1E).	  Whereas	   the	   levels	  of	  miR-­‐15a	  were	  
also	  elevated	   (p=0.039)	   in	   the	   total	  RNA	   levels	  of	   the	  amygdala	   tissue,	  FKBP51	   levels	  were,	  as	  
expected,	   decreased	   (p=0.008)	   (Figure	   1F),	   supporting	   the	   possibility	   that	   FKBP51	   is	   directly	  
down-­‐regulated	   by	  miR-­‐15a	   in	   the	   amygdala.	   Consistently,	   the	   protein	   levels	   of	   FKBP51	  were	  
measured	  and	  a	  reduction	  of	  25%	  in	  its	  levels	  was	  observed	  (p=0.014)	  (Figure	  1G).	  Interestingly,	  
the	   levels	   of	  miR-­‐15a	  were	   also	   elevated	   by	   60%	   in	   the	   plasma	   of	  mice	   subjected	   to	   chronic	  
stress	   (p=0.047),	   whereas	   the	   levels	   of	  miR-­‐124,	   an	   abundant	   brain	  miRNA,	   were	   unchanged	  
(Figure	   S2	   A-­‐B),	   implicating	   miR-­‐15a	   as	   a	   possible	   marker	   for	   chronic	   stress	   exposure.	   These	  
experiments	  led	  us	  to	  focus	  on	  miR-­‐15a	  and	  FKBP51	  and	  address	  their	  involvement	  in	  mediating	  
chronic	  stress	  cellular	  processes.	  	  
MiR-­‐15a	  transcription	  regulation	  
MiR-­‐15a	  is	  located	  on	  chromosome	  14	  as	  part	  of	  a	  cluster	  with	  miR-­‐16-­‐1	  (Figure	  2A),	  indicating	  
that	  these	  2	  miRNAs	  are	  cotranscribed.	  Previous	  studies	  have	  demonstrated	  that	  the	  promoter	  
for	   miR-­‐15a	   and	   miR-­‐16-­‐1	   is	   likely	   to	   be	   the	   promoter	   for	   DLEU2,	   a	   non-­‐coding	   gene	   that	  
contains	   the	   transcript	   for	  miR-­‐15a	   (Zhang	  et	  al.,	   2012).	  Although	  both	  miR-­‐15a	  and	  miR-­‐16-­‐1	  
share	  a	  seed	  sequence,	  their	  mature	  miRNA	  sequence	  differs	  in	  several	  nucleotides	  (Figure	  2B).	  
In	  addition,	  the	  total	  levels	  of	  miR-­‐16	  in	  most	  brain	  areas	  appear	  to	  be	  higher	  than	  that	  of	  miR-­‐
15a	  (Figure	  2C),	  possibly	  since	  miR-­‐16	  has	  2	  copies	  in	  the	  genome	  (miR-­‐16-­‐1	  on	  chromosome	  14	  
and	   miR-­‐16-­‐2	   on	   chromosome	   3),	   which	   both	   give	   rise	   to	   a	   similar	   mature	   form	   of	   miR-­‐16,	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whose	  genomic	  origin	  is	  indistinguishable.	  Importantly,	  the	  elevation	  in	  miR-­‐15a	  levels	  observed	  
in	   our	   Ago2	   IP	   is	   specific	   for	   this	   miRNA	   and	   not	   for	   miR-­‐16	   (Figure	   2D),	   implying	   miR-­‐15a	  
specificity	  at	  the	  level	  of	  the	  Ago2	  complex	  formation.	  
FKBP51	  is	  a	  confirmed	  target	  of	  miR-­‐15a	  	  
Consistent	  with	  direct	  targeting	  of	  FKBP51	  by	  miR-­‐15a,	  the	  seed	  sequence	  for	  miR-­‐15a	  binding	  
at	  the	  3'-­‐UTR	  of	  FKBP51	  is	  highly	  conserved	  (Figure	  3A).	  Moreover,	  a	  luciferase	  assay	  in	  which	  a	  
construct	   containing	   luciferase	   followed	   by	   the	   3'-­‐UTR	   of	   FKBP51,	   was	   constructed	   and	  
transfected	   into	   Huh7	   cells	   expressing	   either	  miR-­‐15a	   or	   a	   scramble	   control	   for	   it,	   showed	   a	  
robust	   specific	   reduction	   in	  normalized	   luciferase	   levels	   (Figure	  3B,	  p<0.001).	   Importantly,	   this	  
reduction	   was	   abolished	   when	   the	   miR-­‐15a	   seed	   sequence	   was	   mutated	   (Figure	   3B).	   These	  
results	  support	  a	  regulatory	  role	  for	  miR-­‐15a	  in	  directly	  controlling	  FKBP51	  levels.	  	  
Over-­‐expression	  of	  miR-­‐15a	  in	  the	  basolateral	  amygdala	  does	  not	  affect	  anxiety-­‐like	  behavior	  
To	   examine	  whether	   increased	   levels	   of	  miR-­‐15a	   in	   the	   amygdala	   are	   sufficient	   to	  mimic	   the	  
behavioral	   effects	   associated	   with	   chronic	   stress	   exposure,	   we	   designed,	   constructed	   and	  
produced	  lentiviruses	  over-­‐expressing	  the	  precursor	  of	  miR-­‐15a	  or	  a	  scramble	  miR	  sequence	  as	  
a	   control	   (Figure	   S3A).	   The	   degree	   of	   infection	   and	   the	   levels	   of	   miR-­‐15a	   expression	   were	  
verified	   using	   qPCR	   on	   RNA	   samples	   extracted	   from	   amygdala	   punches	   obtained	   from	   mice	  
injected	   with	   these	   viruses	   into	   the	   BLA.	   The	   treated	   mice	   showed	   an	   approximately	   2-­‐fold	  
increase	  in	  the	  level	  of	  amygdalar	  miR-­‐15a	  compared	  to	  scramble	  control	  (p<0.001;	  Figure	  S3B),	  
which	  is	  similar	  to	  the	  elevated	  levels	  of	  miR-­‐15a	  observed	  following	  exposure	  to	  chronic	  stress	  
(Figure	  1F).	  To	  assess	  the	  stress-­‐related	  behavioral	  changes	  of	  mice	  expressing	  higher	   levels	  of	  
miR-­‐15a,	   mice	   were	   injected	   bilaterally	   into	   the	   BLA	   with	   either	   miR-­‐15a	   over-­‐expressing	   or	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control-­‐scrambled	   viruses	   under	   basal	   or	   chronic	   stress	   conditions	   (Figure	   S3	   C-­‐E).	   Behavioral	  
assessment	  of	  the	  injected	  mice	  indicated	  no	  significant	  changes	  between	  mice	  over-­‐expressing	  
miR-­‐15a	  or	   a	   control	   scramble	  miR	   in	   the	  open	   field	   test,	   or	   in	   the	  elevated	  plus	  maze	   (EPM)	  
test,	  under	  baseline	  (Figure	  S4A	  and	  S4C)	  or	  chronic	  stress	  (Figure	  S4B	  and	  S4D)	  conditions.	   In	  
addition,	  no	  changes	  were	  observed	  in	  the	  locomotor	  activity	  or	  total	  time	  traveled	  in	  the	  open	  
field	  of	  mice	  over-­‐expressing	  miR-­‐15a	  compared	  to	  control	  scramble	  miR	  under	  basal	  (Figure	  S4	  
E-­‐G)	  or	  chronic	  stress	  conditions	  (Figure	  S4	  H-­‐J).	  We	  therefore	  concluded	  that	  over-­‐expression	  of	  
miR-­‐15a	  in	  the	  BLA	  is	  not	  sufficient	  to	  mimic	  the	  behavioral	  effects	  associated	  with	  exposure	  to	  
chronic	  social	  defeat.	  	  
Reduced	   levels	   of	   miR-­‐15a	   in	   the	   basolateral	   amygdala	   increases	   anxiety-­‐like	   behavior	  
following	  exposure	  to	  chronic	  stress	  
Next	  we	  assessed	  the	  requirement	  of	  endogenous	  amygdalar	  miR-­‐15a	  levels	  for	  the	  behavioral	  
responses,	   under	   baseline	   and	   chronic	   stress	   conditions.	   We	   designed,	   constructed	   and	  
produced	  a	  viral	  vector	  containing	  multiple	  binding	  sites	   for	  miR-­‐15a	   (miR-­‐15a	  Sponge),	  which	  
enabled	   knockdown	   (KD)	   of	   miR-­‐15a	   levels	   in	   the	   BLA	   (Figure	   4A).	   The	   control	   sponge	   viral	  
construct	  was	  generated	  by	  specifically	  mutating	  four	  base	  pairs	  on	  each	  side	  of	  the	  bulge	  of	  the	  
sponge	  (Figure	  4A).	  Injection	  of	  the	  miR-­‐15a	  KD	  or	  control	  sponge	  viruses	  into	  the	  BLA	  of	  mice,	  
regardless	   of	   their	   exposure	   to	   chronic	   social	   defeat,	   resulted	   in	   an	   approximately	   2.5-­‐fold	  
reduction	   in	   the	   levels	   of	  miR-­‐15a	   in	   the	   BLA	   under	   basal	   conditions	   (p=0.019)	   and	   following	  
social	   defeat	   (p=0.012)	   (Figure	   4B-­‐C).	   Whereas	   a	   reduction	   was	   observed	   independently	   of	  
chronic	   stress,	   the	   absolute	   levels	   of	  miR-­‐15a	  were	   higher	   in	   the	   chronic	   social	   defeat	   group	  
compared	   to	   controls	   (Figure	   4C).	   This	   supports	   our	   initial	   observation	   regarding	   elevation	   in	  
miR-­‐15a	  levels	  in	  the	  amygdala	  following	  chronic	  social	  defeat.	  The	  BLA	  of	  an	  additional	  group	  of	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mice	  was	   injected	  with	  miR-­‐15a	   sponge	  and	  a	   control	   sponge	  virus	   (Figure	  S5A)	  and	  RNA	  was	  
extracted.	  The	  levels	  of	  miR-­‐15a	  were	  confirmed	  to	  be	  reduced	  by	  40%	  (p=0.009)	  using	  real	  time	  
PCR	   (Figure	   S5B).	   These	   samples	   were	   also	   sequenced	   by	   Illumina	   TruSeq	   Small	   RNA	   Library	  
Preparation	   Kit	   and	   no	   significant	   changes	   were	   observed	   in	   the	   25	   most	   abundant	   miRNAs	  
(Figure	  4D),	   thus	   verifying	   a	   specific	   knockdown	   for	  miR-­‐15a.	  As	   expected	   from	  our	   luciferase	  
assay,	  FKBP51	  mRNA	  levels	  were	  elevated	  in	  the	  BLA	  of	  mice	  injected	  with	  the	  miR-­‐15a	  KD	  virus	  
(p=0.033,	   Figure	   4E).	   The	   protein	   levels	   of	   FKBP51	   were	   increased	   by	   approximately	   50%	  
(p=0.022,	  Figure	  4	  F-­‐G)	  following	  injection	  of	  miR-­‐15a	  knockdown	  or	  control	  viruses.	  
We	   next	   assessed	   the	   miR-­‐15a	   KD	   mice	   for	   anxiety-­‐like	   behavior	   using	   the	   EPM	   test.	   Under	  
baseline	   conditions	   (in	  which	  mice	  were	   not	   exposed	   to	   chronic	   social	   defeat)	   a	   tendency	   to	  
main	  effect	  was	  observed	  (p=0.058).	  No	  significant	  changes	  were	  observed	  in	  the	  time	  spent	  in	  
the	   open	   arms,	   number	   of	   visits	   to	   the	   open	   arms	   or	   distance	   travelled	   in	   the	   open	   arms	  
between	  the	  miR-­‐15a	  KD	  and	  control	  groups	  (Figure	  5	  A-­‐C).	  Similarly,	  the	  locomotor	  activity	  and	  
the	  total	  distance	  traveled	  in	  the	  open	  field	  test	  showed	  no	  differences	  between	  these	  groups	  
(Figure	   H-­‐J).	   Intriguingly,	   however,	   following	   chronic	   social	   defeat	   a	  main	   effect	   between	   the	  
behavior	  of	  miR-­‐15a	  KD	  and	  control	  mice	  was	  observed	  (p=0.026).	  Mice	  with	  miR-­‐15a	  KD	  spent	  
significantly	  less	  time	  in	  the	  open	  arms	  (p=0.009)	  (Figure	  5D,	  G)	  and	  traveled	  less	  distance	  in	  the	  
open	  arms	  (p=0.002)	  (Figure	  5F,	  G)	  relative	  to	  controls	  (asterisks	  indicate	  significance	  following	  
correction	  with	  Bonferroni	  correction	  for	  multiple	  testing).	  No	  differences	  were	  observed	  in	  the	  
number	   of	   visits	   to	   the	   open	   arms,	   the	   locomotor	   activity	   between	   the	   groups,	   or	   the	   total	  
distance	  traveled	   in	  the	  open	  field	  test	  (Figure	  5E,	  K-­‐M).	  These	  results	  demonstrate	  that	  KD	  of	  
miR-­‐15a	   levels	   in	   the	  amygdala	   specifically	   impaired	   the	   recovery,	   and	  behavioral	   response	  of	  
mice	   following	   their	  exposure	   to	  chronic	   stress.	   In	   the	  open	   field	   test,	  miR-­‐15a	  KD	  mice	  spent	  
less	   time	   in	   the	   center	   of	   the	   arena	   (p=0.032)	   but	   no	   changes	  were	   observed	   in	   the	   distance	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traveled	  in	  the	  center	  or	  the	  number	  of	  visits	  to	  the	  center	  (Figure	  S5C).	  Following	  chronic	  social	  
defeat,	   miR-­‐15a	   KD	   and	   control	   mice	   spent	   similarly	   less	   time	   in	   the	   center	   of	   the	   arena	  
suggesting	   a	   “floor	   effect”.	   However,	   miR-­‐15a	   KD	  mice	   showed	   a	   tendency	   to	   travel	   for	   less	  
distance	  in	  the	  center	  of	  the	  arena	  (p=0.060)	  and	  made	  fewer	  visits	  to	  the	  center	  of	  the	  arena	  
(p=0.041)	   (Figure	  S5D).	  These	   results	  are	   in	  accordance	  with	  Hartmann	  et	  al	   (Hartmann	  et	  al.,	  
2015)	  who	  observed	   	   induced	  anxiety-­‐related	  behavior	   following	  over-­‐expression	  of	  FKBP51	   in	  
the	  BLA.	  Moreover,	  Attwood	  et	  al	  (Attwood	  et	  al.,	  2011)	  showed	  that	  silencing	  of	  FKBP51	  levels	  
in	  the	  BLA	  by	  injection	  of	  lentiviral	  short	  hairpin	  RNA	  led	  to	  a	  reduction	  in	  anxiety	  levels	  in	  the	  
EPM.	  Taken	   together,	   the	  current	  data	   suggest	   that	  amygdalar	  miR-­‐15a	   levels	  are	   functionally	  
important	   in	   regulating	   the	   behavioral	   response	   to	   challenge	   and	   suggest	   that	   this	   effect	   is	  
mediated,	  at	  least	  in	  part,	  via	  a	  reduction	  of	  FKBP51	  levels.	  	  
MiR-­‐15a	  is	  regulated	  by	  glucocorticoids	  and	  trauma	  in	  human	  samples	  
To	   examine	   the	   potential	   parallel	   role	   of	   miR-­‐15a	   in	   the	   human	   stress	   response,	   we	   first	  
analyzed	   miR-­‐15a	   expression	   levels	   in	   RNA	   extracted	   from	   peripheral	   blood	   cells	   of	   young	  
healthy	  male	  subjects	  following	  administration	  of	  the	  GR	  agonist	  dexamethasone	  (1.5	  mg	  p.o.).	  
We	  observed	  a	  significant	  up-­‐regulation	  of	  miR-­‐15a	  3	  and	  6	  hours’	  post-­‐treatment	  (Figure	  6A),	  
indicating	   that	  miR-­‐15a	   is	   potentially	   regulated	  by	   activation	  of	   the	   stress	  hormone	   system	   in	  
humans.	   In	  addition,	  we	  performed	  miRNA	  analyses	  on	  peripheral	  blood	  cells	  of	   subjects	  with	  
childhood	  trauma	  and	  control	  subjects	  matched	  for	  age	  and	  gender	  with	  no	  history	  of	  early	  life	  
stress.	  We	  found	  that	  the	  levels	  of	  miR-­‐15a	  were	  significantly	  higher	  by	  32%	  in	  subjects	  exposed	  
to	  childhood	   trauma	  as	  compared	   to	  control	   subjects	  who	  were	  not	  exposed	   (p=0.000,	  Figure	  
6B).	  	  Taken	  together,	  these	  results	  support	  a	  functional	  association	  between	  the	  blood	  levels	  of	  
miR-­‐15a	  and	  psychiatric	  impairment.	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DISCUSSION	  
The	  current	  study	  reveals	  an	  important	  role	  for	  amygdalar	  miR-­‐15a	  in	  regulating	  the	  behavioral	  
responses	   to	   chronic	   stressful	   challenges.	   miR-­‐15a	   levels	   are	   significantly	   increased	   in	   the	  
amygdala	   of	   mice	   subjected	   to	   chronic	   stress,	   and	   amygdala-­‐specific	   knockdown	   of	   miR-­‐15a	  
changes	  the	  behavioral	  responses	  to	  chronic	  stressful	  challenges.	  A	  target	  of	  miR-­‐15a,	  FKBP51,	  
identified	  in	  our	  studies,	  has	  been	  implicated	  in	  a	  number	  of	  stress-­‐related	  psychiatric	  disorders	  
(Binder	  et	  al.	  2009;Zannas	  et	  al.	  2016).	  FKBP51	  is	  part	  of	  the	  immunophilin	  protein	  family	  and	  is	  
known	   to	   play	   a	   role	   in	   glucocorticoid	   receptor	   (GR)	   transcriptional	   activation	   following	  
elevation	   of	   cortisol	   (Gillespie	   et	   al.,	   2009b).	  Manipulation	   of	   FKBP51	   levels	   in	   the	   BLA	   using	  
small	   interfering	   RNA	   (Attwood	   et	   al.,	   2011)	   or	   its	   over-­‐expression	   using	   a	   viral	   vector	  
(Hartmann	  et	   al.,	   2015)	  has	  been	   linked	   to	   changes	   in	   anxiety-­‐like	  behavior.	   FKBP51,	  which	   is	  
strongly	   implicated	   in	  a	  number	  of	   stress-­‐related	  psychiatric	  disorders	  and	   currently	   a	   leading	  
target	   for	   pharmacological	   manipulation	   for	   the	   treatment	   of	   various	   psychopathologies,	   is	  
robustly	  regulated	  both	  in	  vitro	  and	  in	  vivo	  by	  miR-­‐15a.	  Importantly,	  miR-­‐15a	  is	  upregulated	  by	  
pharmacological	   activation	  of	   the	   stress	   response	   in	  humans	  by	  dexamethasone	   treatment	   as	  
well	  as	  exposure	  to	  early	  adverse	  life	  events.	  Therefore,	  miR-­‐15a	  might	  represent	  an	  important	  
target	  for	  the	  treatment	  of	  stress-­‐related	  psychopathologies.	  
Our	  results	   imply	  that	   in	  the	  chronic	  stress	  response,	  miR-­‐15a	  and	   its	  target	  FKBP51	  represent	  
major	  components	  for	  the	  following	  reasons:	  Although	  miR-­‐15a	  is	  bioinformatically	  predicted	  to	  
target	  other	  stress-­‐	  and	  depression/anxiety-­‐related	  transcripts	  such	  as	  GILZ	  or	  Sgk1	  (Anacker	  et	  
al.,	  2013;	  Thiagarajah	  et	  al.,	  2014),	  the	  mRNA	  levels	  of	  these	  genes	  were	  unchanged	  in	  our	  Ago2	  
IP	   array	   (data	   not	   shown)	   supporting	   the	   specificity	   of	   the	   assay.	   In	   the	   current	   study,	   we	  
focused	  exclusively	  on	  miR-­‐15a	   regulation	  of	   FKBP51	  due	   to	   the	   reported	   involvement	  of	   this	  
gene	  in	  stress	  response	  regulation	  and	  stress-­‐linked	  psychopathologies	  (Hartmann	  et	  al.,	  2015;	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Hartmann	   et	   al.,	   2012;	   Scharf	   et	   al.,	   2011).	   Furthermore,	   FKBP51	  mRNA	  was	   detected	   in	   the	  
Ago2	  complex	  implicating	  a	  direct	  binding	  to	  the	  RNAi	  machinery.	  Finally,	  a	  significant	  decrease	  
in	  FKBP51	  levels	  was	  observed	  in	  the	  total	  RNA	  samples	  that	  concomitantly	  exhibited	  elevated	  
miR-­‐15a	  levels.	  	  
While	   BLA-­‐specific	   over-­‐expression	   of	   miR-­‐15a	   resulted	   in	   no	   significant	   behavioral	   changes,	  
knocking	   down	   miR-­‐15a	   in	   the	   BLA	   caused	   an	   anxiogenic	   phenotype	   following	   exposure	   to	  
chronic	  stress.	  The	  regulation	  of	  miR-­‐15a	  following	  exposure	  to	  chronic	  stress	  and	  the	  observed	  
anxiogenic	   phenotype	   in	   the	  BLA-­‐miR-­‐15a	   knockdown	  mice	   following	   chronic	   stress	   exposure,	  
may	   suggest	   that	   miR-­‐15a	   is	   specifically	   involved	   in	   regulating	   the	   behavioral	   responses	   to	  
repeated,	  or	  chronic	  stressful	  exposure.	  The	  lack	  of	  an	  anxiolytic	  phenotype	  in	  the	  BLA-­‐miR15a	  
over-­‐expressing	  mice	  could	  be	  explained	  by	  either	   lack	  of	   spatial	   specificity,	  meaning	   that	   the	  
over-­‐expression	   of	   miR-­‐15a	   was	   not	   induced	   in	   endogenously	   relevant	   BLA	   neurons,	   or	   by	   a	  
possible	  “ceiling	  effect”,	   in	  which	  increasing	  levels	  of	  miR-­‐15a	  on	  top	  of	   its	  endogenous	  stress-­‐
induced	   elevation	   is	   not	   effective	   because	   the	   stress	   response	   has	   already	   reached	   its	   full	  
capacity.	   	   However,	   preventing	   the	   elevation	   of	   endogenous	   miR-­‐15a	   in	   the	   BLA	   by	   its	   KD,	  
resulted	  in	  a	  failure	  of	  the	  mice	  to	  mount	  the	  required	  behavioral	  response	  when	  exposed	  to	  a	  
chronic	  stressful	  challenge.	  	  
Finally,	   the	   elevation	   of	   miR-­‐15a	   in	   2	   distinct	   human	   stress-­‐linked	   scenarios,	   namely,	  
administration	   of	   dexamethasone	   to	   healthy	   subjects	   as	   well	   as	   individuals	   exposed	   to	  
childhood	  trauma,	  strongly	  suggests	  its	  involvement	  in	  human	  stress	  conditions.	  Collectively,	  the	  
preclinical	  and	  human	  translational	  results	  presented	  in	  the	  current	  study	  strongly	  suggest	  that	  
alterations	  in	  miR-­‐15a	  levels	  are	  associated	  with	  the	  behavioral	  response	  to	  chronic	  or	  repeated	  
stressful	  challenges	  and	  may	  be	  relevant	   in	  the	  pathogenesis	  of	  adverse	  life	  events	  and	  stress-­‐
 12 
linked	   psychiatric	   disorders	   such	   as	   anxiety.	   Targeting	   miR-­‐15a	   levels	   might	   prove	   to	   be	  
beneficial	  in	  the	  treatment	  of	  these	  conditions.	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EXPERIMENTAL	  PROCEDURES	  
(See	  also	  ONLINE	  METHODS)	  	  
	  
Chronic	  social	  defeat	  stress	  
10-­‐week	  old	  C57BL/6J	  male	  mice	  were	   subjected	   to	   a	   chronic	   social	   defeat	   stress	   protocol	   as	  
previously	  described	   (Krishnan	  et	  al,	  2007).	  Briefly,	   the	  mice	  were	  placed	  randomly	   in	  a	  home	  
cage	  of	  an	  aggressive	  ICR	  mouse	  and	  allowed	  to	  physically	  interact	  for	  five	  minutes.	  During	  this	  
time,	   the	   ICR	   mouse	   attacked	   the	   intruder	   mouse	   and	   the	   intruder	   displayed	   subordinate	  
posturing.	  A	  perforated	  clear	  Plexiglass	  divider	  was	  then	  placed	  between	  the	  animals	  and	  they	  
remained	   in	   the	   same	   cage	   for	   24	   hours	   to	   allow	   sensory	   contact.	   The	   procedure	   was	   then	  
repeated	  with	  an	  unfamiliar	  ICR	  mouse	  for	  each	  of	  the	  next	  10	  days.	  	  
	  
Immunoprecipitation	  of	  Ago2	  protein,	  RNA	  purification	  and	  microarray	  
Pools	  of	  3	  amygdalae	   taken	   from	  3	  mice	   from	  the	  same	  treatment	  group	   (either	  Social	  defeat	  
n=18	  or	  Control	  n=12)	  were	   immunoprecipitated	  using	  Magnetic	  protein	  G	  beads	   (Dynabeads,	  
Invitrogen Life	   Technologies,	   Carlsbad,	   CA)	   and	   Ago2	  monoclonal	   antibody	   (WAKO	   chemicals	  
GmbH,	  Neuss,	  Germany).	  	  
RNA	   from	  the	  Ago2	   immunoprecipitation	  samples	  was	   isolated	  and	  analyzed	  on	  an	  Affymetrix	  
miRNA	   2.0	   array	   (enriched	   RNA	   protocol)	   and	   an	   Affymetrix	   Mouse	   Gene	   1.0	   ST	   array	  
(Affymetrix,	  Santa	  Clara,	  CA).	  
	  
Cloning	  of	  3'-­‐UTRs	  into	  Psicheck2	  luciferase	  expression	  plasmid	  
The	   3'-­‐UTR	   sequence	   of	   FKBP51	  was	   PCR	   amplified	   from	  mouse	   genomic	  DNA.	   This	  mutation	  
replaced	  the	  first	  4	  nucleotides	  in	  the	  miR-­‐15a	  seed	  sequence	  of	  FKBP51.	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Design,	  construction	  and	  validation	  of	  miR-­‐15	  lentiviruses	  
The	  miR-­‐15a	  over-­‐expression	   vector	  was	   cloned	   following	   the	  human	   synapsin	   promoter.	   The	  
miR	   scramble	   control	   was	   purchased	   from	   GeneCopoeia	   (Rockville,	   MD).	   The	   H1-­‐miR-­‐15a	  
sponge	  KD	  and	  its	  control	  were	  designed	  according	  to	  Lin	  et	  al.	  (Lin	  et	  al.	  2011).	  
	  
Stereotactic	  intracranial	  injections	  
A	   computer-­‐guided	   stereotaxic	   instrument	   and	   a	   motorized	   nanoinjector	   (Angle	   TwoTM	  
Stereotaxic	   Instrument,	   myNeurolab,	   Leica	   Biosystems,	   Buffalo	   Grove,	   IL)	   were	   used	   as	  
previously	  (Elliott	  et	  al.,	  2010;	  Kuperman	  et	  al.,	  2010;	  Regev	  et	  al.,	  2012).	  
	  	  
Behavioral	  assessments	  
All	  behavioral	  assessments	  were	  performed	  during	  the	  dark	  (active)	  phase	  following	  habituation	  
to	  the	  test	  room	  for	  2	  hours	  before	  each	  test.	  	  
Open-­‐field	  test:	  The	  open-­‐field	  test	  was	  performed	  in	  a	  50	  x	  50	  x	  22	  cm	  white	  box,	  lit	  to	  120	  lux.	  
The	  mice	  were	  placed	  in	  the	  box	  for	  10	  minutes.	  Locomotion	  in	  the	  box	  was	  quantified	  using	  a	  
video	  tracking	  system	  (VideoMot2;	  TSE	  Systems,	  Bad	  Homburg,	  Germany).	  
EPM	  test:	  The	  apparatus	  in	  this	  test	  is	  designed	  as	  a	  plus	  sign	  and	  contains	  2	  barrier	  walls	  and	  2	  
open	  arms.	  During	  the	  5-­‐minute	  test,	  which	   is	  performed	   in	  relative	  darkness	  (6	   lux).	  Data	  are	  
scored	  using	  a	  video	  tracking	  system	  (VideoMot2,	  TSE	  Systems,	  Bad	  Homburg,	  Germany).	  
Homecage	   locomotion:	   Homecage	   locomotion	   was	   assessed	   using	   the	   InfraMot	   system	   (TSE	  
Systems,	   Bad	   Homburg,	   Germany).	  Measurements	   of	   general	   locomotion	   consisted	   of	   2	   light	  





Data	  are	  expressed	  as	  mean	  ±	  standard	  error	  of	  the	  mean	  and	  were	  performed	  using	  Statistical	  
Package	  for	  the	  Social	  Sciences	  (SPSS)	  software	  (SPSS	  Inc.,	  Chicago,	  IL).	  	  
	  
Human	  studies	  -­‐	  Dexamethasone	  
Dexamethasone	   unstimulated	   peripheral	   blood	   samples	   were	   drawn	   at	   12:00pm	   followed	   by	  
oral	   administration	   of	   1.5	   mg	   of	   dexamethasone.	   Subsequently	   stimulated	   samples	   were	  
collected	  at	  1:00pm,	  3:00pm,	  6:00pm,	  and	  at	  11:00am	  the	  following	  day.	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FIGURE	  LEGENDS	  
Figure	  1.	  MiR-­‐15a	  is	  elevated	  following	  chronic	  stress	  and	  potentially	  regulates	  FKBP51.	  	  
(A)	  Schematic	  illustration	  of	  the	  social	  defeat	  paradigm.	  C57	  mice	  are	  subjected	  to	  5	  minutes	  of	  
physical	   contact	   (left	  panel)	  with	  an	  aggressive	   ICR	  mouse	   followed	  by	   sensory	   contact	   for	  24	  
hours	   (right	   panel).	   (B)	   Social	   avoidance	   test.	   Unstressed	   mice	   spend	   more	   time	   in	   the	  
interaction	   zone	   following	   introduction	   of	   an	   unfamiliar	   mouse	   (t(16)=-­‐3.657,	   p=0.002).	  
Susceptible	  mice	  spend	  less	  time	  in	  the	  interaction	  zone	  following	  introduction	  of	  an	  unfamiliar	  
mouse	  (t(16)=3.133,	  p=0.006).	  Resilient	  mice	  spend	  more	  time	  in	  the	  interaction	  zone	  following	  
introduction	   of	   an	   unfamiliar	  mouse	   (t(16)=-­‐2.358,	   p=0.031).	   (C)	   Extracts	   of	   the	   amygdalae	   of	  
mice	   subjected	   to	   social	   defeat	   were	   used	   for	   immunoprecipitation	   (IP)	   with	   anti-­‐Ago2.	   The	  
bound	   RNA	   was	   analyzed	   on	   a	   miRNA	   array	   (4	   control	   arrays,	   n=12	   animals;	   6	   social	   defeat	  
arrays,	  n=18	  animals)	  and	  a	  gene	  expression	  array	  (3	  control	  arrays,	  n=9	  animals;	  6	  social	  defeat	  
arrays,	  n=18	  animals).	  (D)	  Log2	  miRNA	  expression	  analysis.	  Four	  miRNAs	  were	  elevated	  and	  ten	  
miRNAs	   were	   decreased	   in	   the	   amygdala	   Ago2	   complex	   following	   social	   defeat.	   (E)	   miR-­‐15a	  
levels	   were	   elevated	   in	   the	   Ago2	   precipitate	   (t(7)=7.147,	   p=0.0002)	   as	   was	   FKBP51	   mRNA	  
(t(7)=5.352,	   p=0.0011).	   (F)	   MiR-­‐15a	   was	   also	   elevated	   in	   total	   RNA	   extracted	   from	   mice	  
amygdalae	  (n=5)	  following	  social	  defeat	  (t(8)=2.46,	  p=0.039)	  whereas	  FKBP51	  levels	  (n=5)	  were	  
decreased	   (t(8)=3.531,	   p=0.008).	   (G)	   FKBP51	   protein	   levels	   following	   social	   defeat.	   FKBP51	  







Figure	  2. 	  MicroRNA	  15a	  and	  16-­‐1	  are	  differentially	  expressed	  following	  chronic	  stress.	  	  
(A)	  Schematic	   illustration	  of	  the	  miR-­‐15a	  and	  miR-­‐16-­‐1	  transcript.	   (B)	  Alignment	  of	  the	  mature	  
sequence	  of	  miR-­‐15a	  and	  miR-­‐16.	  (C)	  The	  distribution	  of	  miR-­‐15a	  and	  miR-­‐16	  in	  different	  brain	  
regions.	  (D)	  Comparison	  of	  the	  amygdala	  Ago2	  IP	  results	  of	  miR-­‐15a	  and	  miR-­‐16.	  	  
	  
Figure	  3.	  FKBP51	  is	  regulated	  by	  miR-­‐15a	  in	  vitro.	  
(A)	  Schematic	  illustration	  of	  FKBP51	  3'-­‐UTR	  indicating	  the	  conserved	  seed	  match	  for	  miR-­‐15a.	  (B)	  
Luciferase	  assay	  with	  luciferase	  fused	  to	  the	  3'-­‐UTR	  of	  FKBP51	  containing	  intact,	  or	  a	  control	  of	  
mutated	   seed	   site	   for	   miR-­‐15a	   in	   the	   presence	   of	   miR-­‐15a,	   or	   control	   scramble	   miR	   (n=6)	  
showed	  a	  50%	  decrease	  in	  luciferase	  levels	  (t(10)=9.083,	  p=0.000).	  This	  decrease	  was	  abolished	  
when	  the	  intact	  FKBP51	  3'-­‐UTR	  contained	  a	  miR-­‐15a	  mutated	  seed.	  
	  
Figure	  4.	  Knockdown	  of	  miR-­‐15a	  in	  the	  BLA	  results	  in	  increased	  FKBP51	  levels	  in	  the	  BLA.	  	  
(A)	   Schematic	   illustration	   of	   lentiviral	   GFP-­‐labeled	   constructs	   of	   control	   and	   sponge	   used	   to	  
knockdown	   (KD)	  miR-­‐15a.	   (B)	   Representative	  microscope	   image	   of	   virally	   infected	   basolateral	  
amygdala	   (BLA)	   of	   a	   10-­‐week	   old	   mouse	   following	   injection	   of	   lentiviral	   miR-­‐15a	   KD	   with	  
enlargement	   of	   the	   BLA	   region	   that	   corresponds	   to	   the	   injection	   site	   (Paxinos	   and	   Franklin	  
digital	  mouse	  brain	  atlas).	   (C)	   left:	  Decreased	  miR-­‐15a	   levels	   in	   the	  BLA	   (n=4)	  of	  mice	   injected	  
with	   miR-­‐15a	   KD	   relative	   to	   control	   under	   basal	   conditions	   (t(6)=3.175,	   p=0.019),	   or,	   right:	  
following	   social	   defeat	   (t(6)=3.528,	   p=0.012).	   (D)	  MiRNA	   sequencing	   data.	   No	   differences	   are	  
observed	   in	   the	   top	   25	   most	   abundant	   miRNA	   from	   mice	   injected	   with	   miR-­‐15a	   KD	   virus	  
compared	  with	   the	   control	   virus.	   (E)	   Elevated	  FKBP51	   levels	   in	   the	  BLA	   (n=7)	  of	  mice	   injected	  
with	  miR-­‐15a	  KD	  relative	  to	  control	  (t(12)=-­‐2.413,	  p=0.033).	  (F)	  FKBP51	  protein	  levels	  following	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miR-­‐15a	  KD	  virus	  injection	  to	  the	  BLA.	  FKBP51	  protein	  levels	  are	  upregulated	  in	  the	  BLA	  of	  mice	  
injected	  with	  miR-­‐15a	  KD	  virus	  compared	  with	  control	  virus	  (t(6)=-­‐3.060,	  p=0.022	  	  
Figure	  5.	  Mice	  with	  virally	  mediated	  reduced	  levels	  of	  BLA-­‐miR-­‐15	  exhibit	  increase	  anxiety-­‐like	  
behavior	  
(A-­‐C)	   Results	   from	   the	   elevated	   plus	   maze	   (EPM)	   test	   of	   mice	   injected	   with	   miR-­‐15a	   KD	   or	  
control	   viruses	   (n=11,	   12)	   showing	   a	   tendency	   (F(3,19)=2.971,	   p=0.058)	   for	   differences.	   No	  
significant	   differences	  were	   observed	   in	   the	   time	   spent	   in	   the	   open	   arms	   (A),	   the	   number	   of	  
visits	  to	  the	  open	  arms	  (B)	  or	  the	  distance	  travelled	  in	  the	  open	  arms	  (C)	  according	  to	  Bonferroni	  
correction	  for	  multiple	  testing.	  (D-­‐F)	  Mice	  injected	  with	  miR-­‐15a	  KD	  or	  control	  viruses	  (n=10,	  9)	  
which	  were	  also	  subjected	  to	  social	  defeat	  showed	  different	  behavior	  in	  the	  EPM	  (F(3,15)=4.08,	  
p=0.026)	   with	   a	   significant	   decrease	   in	   the	   time	   (D)	   (U=13,	   p=0.009)	   and	   distance	   (F)	   (U=7,	  
p=0.002)	  spent	   in	  the	  open	  arms	  of	  the	  EPM	  (corrected	  according	  to	  Bonferroni	  correction	  for	  
multiple	   testing).	  No	  changes	  were	  observed	   in	   the	  number	  of	  visits	   to	   the	  open	  arms	   (E).	   (G)	  
Representative	  tracking	  in	  the	  EPM	  of	  control	  (upper	  panel)	  relative	  to	  miR-­‐15a	  KD	  mice	  (lower	  
panel).	  (H-­‐M)	  No	  changes	  were	  observed	  in	  the	  locomotor	  activity	  and	  total	  distance	  traveled	  in	  
the	   open	   field	   test	   between	   miR-­‐15a	   KD	   and	   control	   mice	   under	   basal	   conditions	   (H-­‐J)	   or	  
following	  social	  defeat	  (K-­‐M).	  	  
Figure	  6.	  miR-­‐15a	  levels	  in	  human	  peripheral	  blood	  is	  higher	  following	  acute	  dexamethasone	  
treatment	  and	  exposure	  to	  childhood	  trauma.	  
(A)	   Relative	  miR-­‐15a	   levels	   in	   peripheral	   blood	   cells	   of	   young	   healthy	  male	   subjects	   following	  
1.5mg	   dexamethasone	   treatment.	   Repeated	   measures	   ANOVA:	   F(4,22)=4.42	   p=0.009.	   *	  
indicates	   p<0.05,	   **	   indicates	   p<0.01.	   A	   significant	   upregulation	   of	   miR-­‐15a	   was	   observed	   3	  
(t(25)=-­‐2.240,	  p=0.034)	  and	  6	  (t(25)=-­‐3.487,	  p=0.002)	  hours	  post-­‐treatment.	   	   (B)	  Levels	  of	  miR-­‐
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15a	   in	   blood	   of	   subjects	   exposed	   to	   childhood	   trauma	   as	   compared	   to	   subjects	   not	   exposed	  
(t(29.715)=	  -­‐13.776).	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Figure	  2	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Figure	  5	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SUPPLEMENTAL	  INFORMATION	  
Figure	  S1:	  miRNA	  and	  gene	  array	  results	  
(A)	  A	  list	  of	  miRNAs	  that	  were	  significantly	  (step	  up	  p	  value<0.01)	  up	  and	  down	  regulated	  in	  RNA	  
from	  IP	  of	  amygdala	  Ago2	  complex	  following	  chronic	  stress	  in	  mice.	  (B)	  A	  list	  of	  genes	  that	  were	  
significantly	   (p	  value<0.05)	  up	  and	  down	  regulated	   in	  RNA	  from	   IP	  of	  amygdala	  Ago2	  complex	  
following	  chronic	  stress	  in	  mice.	  
	  
Figure	  S2:	  miR-­‐15a	  levels	  are	  elevated	  in	  mice	  plasma	  following	  social	  defeat.	  
Real	   time	   PCR	   analysis.	   (A)	   The	   levels	   of	  miR-­‐15a	   (n=6)	  were	   increased	   by	   60%	   (t(10)=-­‐2.265,	  
p=0.047)	   in	   plasma	   of	  mice	   subjected	   to	   the	   chronic	   social	   defeat	   paradigm	  whereas	   (B)	   the	  
levels	  of	  miR-­‐124	  (n=7,6)	  remained	  unchanged.	  
	  
Figure	  S3:	  Construction	  and	  validation	  of	  miR-­‐15a	  over-­‐expressing	  lentiviruses.	  	  
(A)	   Schematic	   illustration	   of	   the	   Syn-­‐miR-­‐15a	   over-­‐expression	   (OE)	   and	   scramble	   control	  
lentiviral	  constructs.	  (B)	  miR-­‐15a	  levels	  in	  the	  basolateral	  amygdala	  (BLA)	  (n=6)	  of	  mice	  injected	  
with	   miR-­‐15a	   OE	   or	   control	   (scramble)	   lentiviruses	   under	   basal	   conditions	   (t(10)=-­‐6.147,	  
p=0.000).	   (C)	   Schematic	   representation	   of	   the	   site	   of	   delivery.	   Adapted	   from	   Paxinos	   and	  
Franklin	   digital	   mouse	   brain	   atlas.	   (D)	   Enlargement	   of	   the	   BLA	   region	   corresponding	   to	   the	  
injection	  site.	   (E)	  Representative	  microscope	   image	  of	  a	  virally	   infected	  BLA	   following	  miR-­‐15a	  
injection	  of	  a	  10-­‐week	  old	  mouse.	  
	  
Figure	  S4:	  Anxiety	  and	  depression-­‐like	  behavioral	   tests	  and	   locomotor	  activity	   in	  mice	  over-­‐
expressing	  miR-­‐15a	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(A,	  B)	  No	  significant	  differences	  were	  observed	  in	  the	  open	  field	  test	  between	  BLA	  miR-­‐15a	  OE	  
and	   control	   mice	   under	   basal	   conditions	   (A)	   or	   following	   chronic	   social	   defeat	   (B).	   (C,	   D)	   No	  
significant	   differences	   were	   observed	   in	   the	   EPM	   test	   between	   BLA	   miR-­‐15a	   OE	   and	   control	  
injected	   mice	   under	   basal	   conditions	   (C)	   or	   following	   chronic	   social	   defeat	   (D).	   (E-­‐J)	   No	  
significant	  differences	  were	  observed	  in	  the	  locomotor	  activity	  or	  total	  distance	  traveled	  in	  the	  
open	   field	   test	   between	   BLA	   miR-­‐15a	   OE	   and	   control	   mice	   under	   basal	   conditions	   	   or	   (H-­‐J)	  
following	  chronic	  social	  defeat.	  	  
	  
	  
Figure	  S5:	  Knockdown	  of	  miR-­‐15a	  results	   in	   increased	  anxiety-­‐like	  behavior	   in	  the	  open-­‐field	  
test	  	  
(A)	  Illustration	  of	  miR-­‐15a	  KD	  and	  control	  virus	   injection	  sites.	  Blue	  circles	  represent	  the	  punch	  
area	  used	  for	  RNA	  extraction.	   (B)	  Real	   time	  PCR	  analysis	  of	  miR-­‐15a	   levels	   (n=5).	  The	   levels	  of	  
miR-­‐15a	   were	   significantly	   decreased	   following	   injection	   of	   miR-­‐15a	   KD	   virus	   compared	   to	  
control	  virus	  (t(8)=-­‐3.445,	  p=0.009).	  (C)	  Open-­‐field	  test	  for	  mice	  injected	  with	  miR-­‐15a	  KD	  virus	  
relative	  to	  control	   (n=11,	  12).	  The	  mice	  spent	  significantly	   less	   time	   in	  the	  center	  of	   the	  arena	  
(F(1,22)=5.27,	  p=0.032).	  No	  changes	  were	  observed	   in	   the	  distance	  spent	   in	  center	  or	  visits	   to	  
center.	   	   (D)	  Open-­‐field	  test	   for	  mice	   injected	  with	  miR-­‐15a	  KD	  or	  control	  viruses	  (n=10,	  9)	  and	  
were	  also	  subjected	  to	  social	  defeat.	  There	  were	  no	  differences	  in	  the	  time	  the	  mice	  spent	  in	  the	  
center	  of	  the	  arena	  but	  they	  showed	  a	  tendency	  to	  travel	  less	  distance	  in	  the	  center	  of	  the	  arena	  
(U=22,	  p=0.060)	  and	  had	  fewer	  visits	  to	  the	  center	  of	  the	  arena	  (U=20,	  p=0.041).	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ONLINE	  METHODS	  	  
Animals	  
C57BL/6J	   mice	   and	   ICR	   mice	   (outbred	   mice	   strain,	   also	   known	   as	   CD1)	   (Harlan	   Israel,	   Kiryat	  
Weizmann,	   Rehovot)	   were	   maintained	   in	   a	   pathogen-­‐free	   temperature-­‐controlled	   (22	   ±	   1°C)	  
mouse	  facility	  on	  a	  reverse	  12	  h	  light-­‐dark	  cycle	  at	  the	  Weizmann	  Institute	  of	  Science,	  according	  
to	   institutional	   guidelines.	   Food	   (Harlan	   Israel,	   Kiryat	   Weizmann,	   Rehovot)	   and	   water	   were	  
given	  ad	   libitum.	  C57BL/6J	  mice	  were	  housed	  4	  per	  cage	  whereas	   ICR	  mice	  were	  single	  caged.	  
The	  total	  number	  of	  animals	  used	  for	  the	  Ago2	  IP	  was	  30	  (18	  social	  defeat	  and	  12	  controls).	  The	  
total	  number	  of	  animals	  used	  for	  the	  lentiviruses	  experiment	  was	  40	  in	  total	  (10	  per	  group).	  
	  
Chronic	  social	  defeat	  
10-­‐week	   old	   C57BL/6J	   male	   mice	   were	   subjected	   to	   a	   social	   defeat	   protocol	   as	   previously	  
described	  (Krishnan	  et	  al.	  2007).	  Briefly,	   the	  mice	  were	  placed	  randomly	   in	  a	  home	  cage	  of	  an	  
aggressive	   ICR	  mouse	  and	  allowed	  to	  physically	   interact	   for	   five	  minutes.	  During	  this	  time,	  the	  
ICR	  mouse	   attacked	   the	   intruder	  mouse	   and	   the	   intruder	   displayed	   subordinate	   posturing.	   A	  
perforated	  clear	  Plexiglas®	  divider	  was	  then	  placed	  between	  the	  animals	  and	  the	  mice	  remained	  
in	  the	  same	  cage	  for	  24	  h	  to	  allow	  sensory	  contact.	  The	  procedure	  was	  then	  repeated	  with	  an	  
unfamiliar	   ICR	  mouse	   for	   each	   of	   the	   10	   consecutive	   days.	   Control	  mice	   were	   housed	   in	   the	  
same	   room	  as	   the	   social	   defeat	  mice	   but	  were	   taken	  out	   of	   the	   room	  during	   the	   five-­‐minute	  
interaction	   with	   the	   ICR.	   Control	   mice	   were	   handled	   daily	   and	   housed	   2	   per	   cage	   with	   a	  
perforated	   clear	   Plexiglas®	   divider	   placed	   between	   the	   2	   mice.	   The	   cage	   used	   for	   the	   social	  
defeat	   is	   a	   type	   II	   long	   cage	   for	  mice	   (W	  x	  D	   x	  H)	  15.59	   x	  8.46	   x	  6.77	   inch.	   The	  bedding	  used	  
during	  the	  social	  defeat	  was	  Aspen	  Sami	  bedding	  17304.	  Mice	  were	  not	  lethally	  injured	  although	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superficial	  marks	  were	  observed.	  We	   find	   that	  within	   a	  period	  of	   5	  minutes	   the	  mice	   tend	   to	  
avoid	  major	  injuries.	  
	  
Microdissection	  of	  brain	  sites for	  Ago2	  IP	  	  
Amygdala	  samples	  were	  collected	   from	  social	  defeat	  and	  control	  mice	  8	  days	  after	   the	  end	  of	  
the	  chronic	  social	  defeat	  protocol.	  Tissue	  collection	  and	  processing	  was	  performed	  as	  previously	  
described	   (Lebow	   et	   al.,	   2012;	   Sztainberg	   et	   al.,	   2010).	   Briefly,	   after	   removing	   the	   brain	   and	  
placing	  it	  on	  an	  acryl	  1	  mm	  brain	  matrix	  (Stoelting	  Co.,	  Wood	  Dale,	  IL,	  cat#	  51380),	  2	  mm	  slices	  
were	   taken	   using	   standard	   razor	   blades	   (GEM,	   62-­‐0165)	   based	   on	   designated	   anatomical	  
markers.	   Blunted	   syringes	   of	   different	   diameters	  were	   used	   to	   punch	   out	   the	   amygdala	   from	  
slices	  removed	  from	  the	  matrix.	  
	  
Immunoprecipitation	  of	  Ago2	  protein	  
Pools	  of	  3	  amygdalae	   taken	   from	  3	  mice	   from	  the	  same	  treatment	  group	   (either	  Social	  defeat	  
n=18	  or	  Control	  n=12)	  were	  homogenized	  in	  NP40	  buffer,	  which	  was	  supplemented	  with	  RNase	  
inhibitor,	  protease	  inhibitor	  and	  phosphatase	  inhibitor	  (Roche	  Diagnostics,	  Indianapolis,	  IN).	  The	  
samples	  were	  constantly	  agitated	  for	  2	  h	  at	  4°C.	  Samples	  were	  then	  centrifuged	  for	  20	  min	  at	  
12,000	  rpm	  at	  4°C	  in	  a	  microcentrifuge;	  the	  supernatant	  was	  placed	  in	  a	  fresh	  tube,	  kept	  on	  ice	  
and	   the	   pellet	   was	   discarded.	   Magnetic	   protein	   G	   beads	   (Dynabeads,	   Invitrogen Life	  
Technologies,	   Carlsbad,	   CA)	   were	   incubated	   with	   the	   Ago2	   monoclonal	   antibody	   (WAKO	  
chemicals	   GmbH,	   Neuss,	   Germany)	   with	   rotation	   at	   room	   temperature	   for	   10	  minutes.	   After	  
several	   washes,	   the	   samples	  were	   added	   to	   the	   Ago2-­‐coated	   protein	   G	   beads	   and	   incubated	  
overnight	  at	  4°C	  under	  agitation.	  The	   following	  day	   the	  beads	  were	  washed	  3	   times	  with	  PBS.	  
For	  RNA	  purification,	   the	  beads	  were	  homogenized	   in	  RLT	  buffer	   (RNeasy	  kit,	  QIAGEN,	  Hilden,	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Germany	  -­‐	  miRNA	  supplementary	  protocol).	  For	  western	  blot	  analysis,	  the	  beads	  were	  boiled	  in	  
sample	  buffer	  to	  release	  the	  protein	  from	  the	  beads.	  
	  
RNA	  purification	  and	  microarray	  
RNA	   from	   the	   Ago2	   immunoprecipitation	   samples	   was	   isolated	   using	   the	   RNeasy	   plus	   kit	  
(QIAGEN,	  Hilden,	  Germany)	  following	  QIAGEN’s	  supplementary	  Protocol	  1:	  Purification	  of	  total	  
RNA	  containing	  miRNA.	  RNA	  for	  all	  other	  purposes	  was	  isolated	  from	  frozen	  brain	  punches	  using	  
the	   miRNeasy	   mini	   kit	   (QIAGEN,	   Hilden,	   Germany)	   according	   to	   the	   manufacturer’s	  
recommendation.	   RNA	   derived	   from	   tissues	   of	   stressed	   mice	   following	   Ago2	  
immunoprecipitation	   was	   further	   analyzed	   on	   an	   Affymetrix	   miRNA	   2.0	   array	   (enriched	   RNA	  
protocol)	  and	  an	  Affymetrix	  Mouse	  Gene	  1.0	  ST	  array	  (Affymetrix,	  Santa	  Clara,	  CA).	  
	  
Microarray	  analysis	  
For	  the	  miRNA	  analysis,	  we	  used	  4	  arrays	  for	  the	  control	  mice	  and	  6	  arrays	  for	  the	  social	  defeat	  
mice	  (each	  array	  consists	  of	  a	  pool	  of	  3	  mice).	  We	  used	  step	  up	  correction	  for	  multiple	  testing	  
correction.	  The	  fold	  change	  threshold	  was	  1.75	  with	  a	  p	  value	  of	  p	  <	  0.01.	  For	  the	  gene	  analysis,	  
we	  used	  3	  arrays	  for	  the	  control	  mice	  and	  6	  arrays	  for	  the	  social	  defeat	  mice	  (each	  array	  consists	  
of	  a	  pool	  of	  3	  mice).	  The	  fold	  change	  threshold	  was	  1.3	  with	  a	  p	  value	  of	  p	  <	  0.05.	  
	  
Bioinformatic	  analysis	  of	  microRNA	  microarray	  results	  
miRNAs	  and	  genes	  were	  tested	   in	  3	  different	  web	  based	  programs	   in	  search	   for	  a	  seed	  match	  
between	   a	   miRNA	   and	   a	   3'-­‐UTR:	   Target	   Scan	   (http://www.targetscan.org),	   Miranda	  
(http://www.microrna.org),	  (Betel	  et	  al.,	  2008)	  and	  Pictar	  (http://pictar.mdc-­‐berlin.de).	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Cloning	  of	  3'-­‐UTRs	  into	  Psicheck2	  luciferase	  expression	  plasmid	  
The	  3'-­‐UTR	  sequence	  of	  FKBP51	  was	  PCR	  amplified	  from	  mouse	  genomic	  DNA	  using	  a	  forward	  
primer:	  CCAACTCAGGACTGAACAGT	  and	  a	  reverse	  primer:	  GTTCCTTAGGCTGTGGAGAA.	  The	  DNA	  
sequence	  for	  the	  mutated	  form	  of	  FKBP51	  was	  generated	  by	  site	  directed	  mutagenesis	  using	  the	  
original	   cloning	   primers	   of	   FKBP51	   and	   2	   new	   primers:	   FKBP51-­‐SDM-­‐F	  
ATGACCACCACGGGCTGCGG	   and	   FKBP51-­‐SDM-­‐R	   CCGCAGCCCGTGGTGGTCAT.	   This	   mutation	  
replaced	  the	   first	  4	  nucleotides	   in	   the	  miR-­‐15a	  seed	  sequence	  of	  FKBP51	  from	  TGCT	  to	  ACGG.	  
The	   3'-­‐UTR	   fragments	   were	   then	   ligated	   into	   pGem-­‐T	   easy	   vector	   (Promega,	   Madison,	   WI)	  
according	  to	  the	  manufacturer's	  guidelines,	  and	  further	  subcloned	  into	  a	  single	  NotI	  site	  at	  the	  3'	  
end	  of	  luciferase	  in	  the	  Psicheck2	  reporter	  plasmid	  (Promega,	  Madison,	  WI).	  Cloning	  orientation	  
was	  verified	  by	  diagnostic	  cuts	  and	  sequencing.	  	  
	  
Transfections	  and	  luciferase	  assay	  
Huh7	   cells	   were	   grown	   on	   poly-­‐L-­‐lysine	   coated	   48-­‐well	   plates	   to	   70-­‐85%	   confluence	   and	  
transfected	   using	   polyethylenimine	   with	   the	   following	   plasmids:	   5	   ng	   of	   Psicheck2-­‐	   3'-­‐UTR	  
plasmid	   and	   215	   ng	   of	   EGFP	   over-­‐expressing	   vector	   for	   either	   a	   specific	   miRNA,	   or	   a	   miR-­‐
scramble	   EGFP	   plasmid.	   24	   h	   following	   transfection,	   cells	   were	   lysed	   and	   luciferase	   reporter	  
activity	  was	   assayed	   as	   previously	   described	   (Chen	   et	   al.	   2005).	   Renilla	   luciferase	   values	  were	  
normalized	  to	  control	  luciferase	  levels	  (transcribed	  from	  the	  same	  vector	  but	  not	  affected	  by	  the	  
3'-­‐UTR	  tested)	  and	  averaged	  across	  eight-­‐well	  repetitions	  per	  condition.	  
	  
miRNA	  RT-­‐qPCR	  expression	  analysis	  
Quantitative	   miRNA	   expression	   was	   acquired	   and	   analyzed	   using	   a	   step	   one	   thermocycler	  
(Applied	  Biosystems,	  Waltham,	  MA),	   using	  miRCURY	   LNA	  Universal	   RT	  microRNA	  PCR	  primers	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(Exiqon,	  Vedbaek,	  Denmark)	  or	  miScript	  primer	  assay	  (QIAGEN,	  Hilden,	  Germany).	  RNA	  samples	  
were	  assessed	  using	  miRCURY	  Universal	  cDNA	  Synthesis	  kit	  II	  and	  miRCURY	  ExiLENT	  SYBR	  Green	  
(Exiqon,	   Vedbaek,	   Denmark)	   or	   miScript	   II	   RT	   kit	   and	   miScript	   SYBRgreen	   PCR	   kit	   (QIAGEN,	  
Hilden,	   Germany),	   according	   to	   the	   manufacturer's	   guidelines.	   U6,	   5S	   rRNA	   were	   used	   as	  
internal	  controls.	  Gene	  expression	  was	  obtained	  using	  the	  High	  Capacity	  kit	  and	  SYBR	  green	  PCR	  
master	  mix	   (Applied	   Biosystems,	  Waltham,	  MA).	   The	   real-­‐time	   PCR	  primers	   for	   FKBP51	  were:	  
forward:	  ATGACTACTGATGAGGGCAC	  and	  reverse:	  GACATAAACTTTGTCACCAAAC.	  	  
	  
Design,	  construction	  and	  validation	  of	  miR-­‐15	  lentiviruses	  
The	   miR-­‐15a	   over-­‐expression	   vector	   was	   cloned	   as	   follows:	   the	   enhanced	   form	   of	   human	  
synapsin	   I	   promoter	   (Hioki	   et	   al.	   2007)	   was	   PCR	   amplified	   (forward	   primer:	  
ttttttatcgatctcgagtagttattaatagtaatc,	   reverse	   primer:	   ttttttaccggtggcgcgcccgccgcagcgcagatggt)	  	  
from	   pENTR1A-­‐E/SYN-­‐GFP-­‐WRPE1	   (Kindly	   provided	   by	   Dr.	   Takeshi	   Kaneko,	   Department	   of	  
Morphological	  Brain	  Science,	  Graduate	  School	  of	  Medicine,	  Kyoto	  University,	  Kyoto,	  Japan)	  and	  
inserted	  between	  ClaI	  and	  AgeI	   restriction	  sites	   to	   replace	   the	  CMV	  promoter	   in	  pCSC-­‐SP-­‐PW-­‐
GFP	  (kindly	  provided	  by	  Dr.	   Inder	  Verma,	  The	  Salk	   Institute	  for	  Biological	  Studies,	  La	  Jolla,	  CA).	  




The	  miR	  scramble	  control	  was	  purchased	  from	  GeneCopoeia	  (Rockville,	  MD)	  and	  sub-­‐cloned	  into	  
pCSC-­‐SP-­‐PW-­‐SYN-­‐GFP	  plasmid.	  The	  miR-­‐15a	  sponge	  KD	  and	  its	  control	  were	  designed	  according	  
to	  Lin	  et	  al.	   (Lin	  et	  al.	  2011)	  and	   inserted	   following	  an	  H1	  promoter	   in	   the	  p156RRL-­‐CMV-­‐GFP	  






.	   The	   sequence	   for	   miR-­‐15a	   sponge	   control	   was:	  
CTAGCTAGCCATGTCCCAAGCAGAATGCTAATCGCATGTCCCAAGCAGAATGCTAATCGCATGTCCCAAG
CAGAATGCTAATCGCATGTCCCAAGCAGAATGCTA.	   High	   titer	   lentiviruses	   were	   produced	   as	  
previously	  described	  (Tiscornia	  et	  al.	  2006).	  Briefly,	  recombinant	  lentiviruses	  were	  produced	  by	  
transient	  transfection	  in	  HEK293T	  cells.	  Infectious	  particles	  were	  harvested	  at	  48	  and	  72	  h	  post-­‐
transfection,	   filtered	   through	   0.45	   μm-­‐pore	   cellulose	   acetate	   filters,	   concentrated	   by	  
ultracentrifugation,	  re-­‐dissolved	  in	  sterile	  HBSS,	  aliquoted	  and	  stored	  at	  –80°C.	  	  
	  
Stereotactic	  intracranial	  injections	  
A	   computer-­‐guided	   stereotaxic	   instrument	   and	   a	   motorized	   nanoinjector	   (Angle	   TwoTM	  
Stereotaxic	   Instrument,	   myNeurolab,	   Leica	   Biosystems,	   Buffalo	   Grove,	   IL)	   were	   used	   as	  
previously	  described	  (Elliott	  et	  al.,	  2010;	  Kuperman	  et	  al.,	  2010;	  Regev	  et	  al.,	  2012).	  10-­‐week	  old	  
male	   mice	   were	   randomly	   selected	   and	   anesthetized	   using	   1.5%	   isoflurane	   and	   1	   μl	   of	   the	  
lentiviral	   preparation	   was	   delivered	   to	   each	   BLA	   using	   a	   Hamilton	   syringe	   connected	   to	   a	  
motorized	  nanoinjector	  system	  at	  a	  rate	  of	  0.2	  μl	  per	  min	  (coordinates	  relative	  to	  bregma:	  AP	  =	  
–1.58	   mm,	   L	   =	   ±3.3	   mm,	   H	   =	   –4.6	   mm).	   Following	   a	   2-­‐week	   recovery	   period,	   mice	   were	  
subjected	   to	   behavioral	   studies	   and	   later	   anesthetized	   and	   perfused	   with	   4%	   PFA.	   The	   fixed	  
brains	   were	   serially	   sectioned	   and	   immunohistochemically	   stained	   in	   order	   to	   confirm	   the	  
location	  of	   the	   injection	   site,	  as	   previously	   described	   (Regev	  et	   al.,	   2011).	   The	   antibodies	   that	  
were	  used	  were:	  Goat	  biotinylated	  anti-­‐GFP	   (Abcam,	  Cambridge,	  UK;	  ab6658)	  and	  Alexa	  Fluor	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488	   Streptavidin	   (Jackson	   ImmunoResearch	   Laboratories,	   West	   Grove,	   PA;	   016-­‐540-­‐084).	   	   3	  
repetitions	  were	  used	  for	  the	  immunohistochemical	  analysis.	  
	  
Behavioral	  assessments	  
All	  behavioral	  assessments	  were	  performed	  during	  the	  dark	  (active)	  phase	  following	  habituation	  
to	   the	   test	   room	   for	   2	  hours	  before	  each	   test.	   Behavioral	   tests	  were	   conducted	  as	  previously	  
described	   (Haramati	   et	   al.,	   2011;	   Lebow	   et	   al.,	   2012)	   in	   the	   following	   order,	   from	   the	   least	  
stressful	  procedure	  to	  the	  most	  and	  ending	  with	  home	  cage	  locomotor	  testing:	  Open-­‐field,	  EPM	  
and	  home	  cage	  locomotion.	  
Open-­‐field	  test:	  The	  open-­‐field	  test	  was	  performed	  in	  a	  50	  x	  50	  x	  22	  cm	  white	  box,	  lit	  to	  120	  lux.	  
The	  mice	  were	  placed	  in	  the	  box	  for	  10	  minutes.	  Locomotion	  in	  the	  box	  was	  quantified	  using	  a	  
video	  tracking	  system	  (VideoMot2;	  TSE	  Systems,	  Bad	  Homburg,	  Germany).	  
EPM	  test:	  This	  apparatus	  in	  this	  test	  is	  designed	  as	  a	  plus	  sign	  and	  contains	  2	  barrier	  walls	  and	  2	  
open	   arms.	   During	   the	   5-­‐minute	   test,	   which	   is	   performed	   in	   relative	   darkness	   (6	   lux),	   the	  
number	  of	  entries,	  the	  distance	  traveled	  and	  the	  time	  spent	   in	  the	  open	  arms	   is	  automatically	  
scored	  using	  a	  video	  tracking	  system	  (VideoMot2,	  TSE	  Systems,	  Bad	  Homburg,	  Germany).	  
Homecage	   locomotion:	   Homecage	   locomotion	   was	   assessed	   using	   the	   InfraMot	   system	   (TSE	  
Systems,	  Bad	  Homburg,	  Germany).	  Mice	  were	  housed	  individually	  for	  72	  h,	  in	  which	  the	  first	  24	  
h	  were	  considered	  habituation	   to	   the	   individual	  housing	  conditions.	  Measurements	  of	  general	  
locomotion	  consisted	  of	  2	  light	  and	  2	  dark	  cycles	  in	  the	  last	  48	  h,	  collected	  at	  10	  min	  intervals.	  	  
	  
Statistics	  
Data	   are	   expressed	   as	  mean	   ±	   standard	   error	   of	   the	  mean	   (Binder	   et	   al.).	   Statistical	   analyses	  
were	   performed	   using	   Statistical	   Package	   for	   the	   Social	   Sciences	   (SPSS)	   software	   (SPSS	   Inc.,	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Chicago,	   IL).	   All	   data	   sets’	   distributions	   were	   tested	   for	   normality	   using	   Shapiro-­‐Wilks	   test	   in	  
order	  to	  determine	  which	  statistical	  tests	  should	  be	  applied.	  In	  cases	  where	  indices	  of	  2	  groups	  
were	   compared	   and	   the	   data’s	   distribution	   was	   normal,	   a	   2-­‐sided	   students	   t-­‐test	   was	   used,	  
where	  the	  data	  departed	  from	  normal	  distribution,	  the	  Mann-­‐	  Whitney	  U	  test	  was	  applied.	  All	  
data	   sets	   were	   also	   tested	   for	   variance	   similarity	   between	   compared	   groups.	   For	   the	  miRNA	  
array	  results,	  a	  q-­‐value	  correction	  was	  performed.	  Mice	  were	  excluded	  from	  the	  analysis	  if	  they	  
had	  values	  higher	  than	  AVG+2*SD	  or	  lower	  than	  AVG-­‐2*SD	  
	  
Human	  studies	  -­‐	  qPCR	  analysis	  
Samples:	   For	   this	   study,	   26	   males	   of	   Caucasian	   origin	   aged	   between	   19	   and	   30	   years	   were	  
recruited	   (mean	   age	   =	   25.58	   +/-­‐	   2.64SD).	   All	   participants	  were	   free	  of	   a	   history	   of	   psychiatric	  
disorders	  as	  well	  as	  major	  neurological	  and	  general	  medical	  disorders.	  Further	  exclusion	  criteria	  
were	   regular	   use	   of	   medical	   drugs,	   as	   well	   as	   excessive	   alcohol	   or	   caffeine	   consumption.	   All	  
subjects	  gave	  written	  informed	  consent.	  Procedures	  were	  approved	  by	  the	  Ethics	  Committee	  of	  
the	   Ludwig	   Maximilians	   University,	   Munich,	   Germany,	   in	   accordance	   with	   the	   Declaration	   of	  
Helsinki.	  
Study	  Design:	  Unstimulated	  peripheral	  blood	  samples	  were	  drawn	  at	  12:00pm	  followed	  by	  oral	  
administration	  of	  1.5	  mg	  of	  dexamethasone.	  Subsequently	  stimulated	  samples	  were	  collected	  at	  
1:00pm,	   3:00pm,	   6:00pm,	   and	   at	   11:00am	   the	   following	   day.	   PAXgeneTM	   (QIAGEN,	   Hilden,	  
Germany)	   whole	   blood	   RNA	   collection	   tubes	   were	   used	   at	   each	   time	   point	   for	   whole	   blood	  
collection.	  
RNA	   extraction:	   Total	   RNA	   was	   extracted	   using	   the	   PAXgene	   Blood	   RNA	   Kit	   (PreAnalytiX,	  
Hombrechtikon,	  Switzerland)	  with	  the	  QIAGEN	  method	  for	  column	  purification	  of	  nucleic	  acids	  
(PreAnalytiX,	   Hombrechtikon,	   Switzerland)	   according	   to	   the	   manufacturer’s	   instructions.	   For	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RNA	   quality	   and	   quantity,	   extracted	   samples	   were	   subsequently	   run	   on	   the	   Agilent	   2200	  
TapeStation	   (Agilent	   Technologies,	   Santa	  Clara,	  CA).	  All	   samples	  had	  an	  RNA	   integrity	  number	  
(RIN)	  ≥7.	  
Quantitative	  real	  time	  polymerase	  chain	  reaction:	  Total	  RNA	  was	  reverse	  transcribed	  using	  the	  
miRCURY	  LNA™	  Universal	  RT	  miRNA	  PCR	  cDNA	  synthesis	  kit	  (Exiqon,	  Vedbaek,	  Denmark).	  CDNA	  
was	  diluted	  and	  mixed	  with	  the	  Exiqon	  microRNA	  LNA	  PCR	  primers	  as	  well	  as	  the	  Exiqon	  SYBR	  
Green	  master	  mix	  and	  assayed	  in	  10	  µl	  reactions.	  qPCR	  experiments	  were	  performed	  using	  the	  
Roche	   480	   LightCycler	   system	   (Roche	   Applied	   Science,	   Roche	   Diagnostics,	   Indianapolis,	   IN)	   in	  
384-­‐well	  plates.	  Each	  sample	  was	   run	   in	   technical	   triplicates.	  Normalization	  of	   the	   results	  was	  
performed	  against	  SNORD38	  using	  the	  delta	  Ct	  method.	  	  
	  
Western	  blot	  analysis	  
Frozen	   brain	   samples	   were	   homogenized	   in	   RIPA	   buffer	   supplemented	   with	   proteinase	  
inhibitors	   (Sigma-­‐Aldrich,	   St.	   Louis,	  MO)	   and	  were	   incubated	   on	   ice	   for	   10	  min.	   After	   10	  min	  
centrifugation,	  the	  supernatant	  was	  transferred	  to	  a	  new	  tube	  and	  sample	  buffer	  was	  added	  to	  
the	  sample,	  which	  was	  then	  boiled	  for	  5	  min	  and	  placed	  on	  ice.	  The	  samples	  were	  separated	  in	  a	  
10%	   polyacrylamide	   gel	   electrophoresis.	   Transfer	   was	   performed	   using	   an	   assembly	   of	  
nitrocellulose	  membrane	  and	  Whatman	  paper.	  The	  transfer	  was	  performed	  at	  100v,	  280	  mAmp	  
for	  1h	  and	  40	  minutes.	  After	  washes	  with	  PBST	  (PBS	  +	  20%	  Tween	  20)	  membrane	  was	  blocked	  
with	   10%	  milk	   for	   1	   h.	   The	   first	   antibody	   was	   added	   (goat	   anti	   FKBP51	   –	   Santa	   Cruz	   11518,	  
mouse	  anti-­‐GAPDH	  –	  abcam	  8245	  or	  mouse	  Anti-­‐b-­‐Actin-­‐	  Sigma-­‐Aldrich, St.	  Louis,	  MO;	  A1978)	  
to	   PBST	   and	   placed	   on	   constant	   shaking	   at	   4°C	   overnight	   or	   1	   h	   at	   room	   temperature.	   The	  
second	  antibody	  (anti-­‐goat	  HRP	  –	  abcam	  6885,	  anti-­‐mouse	  HRP	  –	  cell	  signal	  7076)	  was	  added	  in	  
 49 
10%	  milk	   for	   1	   h.	   Each	   step	  was	   separated	   by	   additional	   washes	   with	   PBST.	   Finally,	   ECL	   was	  
added	  to	  the	  membrane	  which	  was	  then	  exposed	  to	  film.	  
Social	  avoidance	  test	  	  
The	  test	  is	  performed	  in	  an	  open	  field	  design	  with	  a	  small	  neighboring	  chamber	  that	  is	  separated	  
from	  the	  open	  field	  with	  a	  divider	  with	  small	  open	  slits,	  allowing	  full	  sensory	  contact	  between	  
the	   2	   fields.	   The	  mice	   are	   allowed	   to	   habituate	   to	   the	   open	   field	   for	   3	  minutes,	   and	   then	   an	  
unfamiliar	  ICR	  mouse	  is	  placed	  in	  the	  neighboring	  chamber,	  and	  they	  are	  allowed	  to	  interact	  for	  
3	  minutes.	   	   The	   entire	   session	   is	   videotaped	   and	   analyzed	   with	   Ethovision	   software	   (Noldus,	  
Wageningen,	  Netherlands).	   	   	  The	  space	  next	   to	   the	  small	  neighboring	  chamber	   is	  deemed	  the	  
interaction	   zone.	   The	   time	   a	   mouse	   spends	   in	   the	   interaction	   zone	   with	   the	   unfamiliar	   ICR	  
mouse	  is	  divided	  by	  the	  time	  the	  mouse	  spent	  in	  the	  interaction	  zone	  without	  the	  unfamiliar	  ICR	  
mouse	  and	  then	  multiplied	  by	  100.	  Mice	  were	  categorized	  into	  3	  groups:	  Control,	  “Susceptible”	  
and	   “Resilient”.	   Mice	   that	   received	   below	   100	   in	   this	   analysis	   were	   characterized	   as	  
“Susceptible”.	  Mice	   that	   received	  above	  100	   in	   this	  analysis	  were	  characterized	  as	   “Resilient”.	  
Only	  control	  mice	  that	  received	  above	  100	  were	  further	  used.	  
miRNA	  Sequencing	  analysis	  
RNA	  samples	  were	  quantified	  by	  Qubit	  and	  400	  ng	  RNA	  used	   for	   library	  preparation	  using	   the	  
Illumina	   TruSeq	   Small	   RNA	   Library	   Preparation	   Kit	   following	   the	   standard	   protocol	   and	   size-­‐
selected	   on	   DNA-­‐PAGE	   to	   a	   size	   of	   145-­‐155nt.	   QC	   was	   carried	   out	   using	   BioAnalyzer	   High	  
Sensitivity	   DNA	   chips	   and	   libraries	   quantified	   using	   the	   KAPA	   library	   Quantification	   Kit	   for	  
Illumina	   (Kapa	   Biosystems	   Inc.,	   Wilmington,	   MA)	   on	   a	   Roche	   Lightcycler480.	   Libraries	   were	  
multiplexed	  in	  euqimolar	  pools	  and	  sequenced	  single-­‐end	  50nt	  on	  an	  Illumina	  MiSeq	  at	  MPI	  of	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Psychiatry,	   München,	   using	   v3	   chemistry	   to	   a	   depth	   of	   minimum	   5Mio	   reads	   per	   sample	   (%	  
>=Q30	  higher	  then	  96).	  	  
Fastq	   raw	   sequence	   reads	   were	   quality-­‐checked	   using	   FASTQC*	   and	   reads	   between	   15-­‐40nt	  
length	   containing	   the	   Illumina	   Small	   RNA	   Adapter	   selected	   and	   adapter-­‐trimmed	   using	  
Cutadapt*.	   Reads	   were	   aligned	   to	   miRbase	   v21	   and	   normalized	   to	   counts	   per	   million	   using	  
sRNAbench*	  (library	  mode	  using	  Bowtie*).	  Differential	  expressed	  microRNAs	  were	  queried	  using	  
the	  Bioconductor	  -­‐	  DESeq2	  package*	  applying	  a	  minimum	  cut-­‐off	  of	  5	  read	  counts	  in	  all	  samples. 
Subjects	  exposed	  to	  early	  life	  trauma	  	  
Control	  subjects	  were	  available	  at	  the	  IRCCS	  Fatebenefratelli	  Institute,	  Brescia	  (Italy).	  Individuals	  
presenting	   a	   history	   of	   neurological	   disease,	   prior	   electro-­‐convulsivant	   treatment,	   prior	  
traumatic	   brain	   injury,	   or	  mental	   retardation	   (IQ<70)	   were	   excluded	   from	   the	   study.	  Written	  
informed	   consent	   was	   obtained	   by	   participants	   after	   receiving	   a	   complete	   description	   of	   the	  
study,	  which	  has	  received	  approval	  by	  the	  local	  ethics	  committee.	  
The	   absence	   of	   psychiatric	   disorder	   was	   ascertained	   via	   2	   schedules:	   the	   Mini	   International	  
Neuropsychiatric	   Interview	   (M.I.N.I.	   Plus,	   Bonora	   et	   al.,	   1995),	   to	   exclude	   any	   psychiatric	  
disorder	  in	  Axis	  I;	  and	  the	  Structured	  Clinical	  Interview	  for	  DSM	  disorders	  (SCID-­‐II,	  Spitzer	  et	  al.,	  
1993)	  to	  exclude	  any	  psychiatric	  disorder	  in	  Axis	  II.	  
The	  list	  of	  traumatic	  events	  includes	  loss	  of	  a	  biological	  parent	  due	  to	  death	  or	  separation	  for	  at	  
least	  6	  months,	  including	  being	  taken	  into	  local	  authority	  care,	  severe	  physical,	  sexual	  abuse	  by	  
a	   parental	   figure	   and	   neglect.	   Physical	   abuse	   includes	   incidents	   that	   meet	   at	   least	   2	   of	   the	  
following	  criteria:	  a)	   the	  abuse	  consisted	  of	  being	  hit	  with	  a	  belt	  or	  stick,	  or	  being	  punched	  or	  
kicked;	  b)	  the	  abuse	  resulted	  in	  an	  injury,	  including	  broken	  limbs,	  black	  eyes	  or	  bruising;	  and	  c)	  
 51 
the	  perpetrator	  was	  considered	  to	  be	  out	  of	  control.	  Sexual	  abuse	  was	  defined	  as	  unwanted	  or	  
illegal	  sexual	  experiences	  prior	   to	  age	  17	  years	  with	  any	  adult	  or	  an	   individual	  at	   least	  5	  years	  
older	   than	   the	   recipient,	   not	   necessarily	   limited	   to	   the	   immediate	   family;	   moreover,	   these	  
experiences	  have	  to	  meet	  at	   least	  2	  of	  the	  following	  criteria:	  a)	  the	  perpetrator	  was	  known	  to	  
the	  individual;	  b)	  the	  perpetrator	  was	  a	  relative;	  c)	  the	  perpetrator	  lived	  in	  the	  same	  household;	  
d)	   the	  unwanted	   sexual	  experience	  occurred	  more	   than	  once;	  e)	   the	  perpetrator	   touched	   the	  
child's	  genitals;	  f)	  the	  perpetrator	  forced	  the	  child	  to	  touch	  the	  perpetrator's	  genitals;	  and	  g)	  the	  
abuse	  involved	  sexual	  intercourse.	  	  
Neglect	   was	   defined	   in	   terms	   of	   parents’	   disinterest	   in	   material	   care	   (feeding	   and	   clothing),	  
health,	  schoolwork	  and	  friendships.	  Neglect	  was	  quantified	  for	  both	  mother	  and	  father.	  	  
The	  most	  conservative	  cut-­‐off	  points	  published	  by	  Bifulco	  et	  al.	  (2005)	  were	  used	  to	  dichotomise	  
these	  responses	  into	  a	  yes/no	  answer.	  For	  this	  study,	  we	  performed	  miRNA	  analyses	  using	  qPCR	  
in	  a	  group	  of	  20	  subjects	  who	  reported	  at	  least	  one	  type	  of	  abuse	  (physical	  abuse,	  sexual	  abuse,	  
physical,	  parents	   separation	  or	   loss	  and	  neglect)	  and	  20	  subjects	  matched	   for	  age	  and	  gender	  
with	  no	  history	  of	  early	  life	  stress	  (mean	  age	  ±	  SD:	  38.1	  ±	  6.1	  and	  37.5	  ±	  6.7	  respectively	  in	  the	  
subjects	  with	  and	  without	  childhood	  trauma,	  p<0.05);	  percentage	  of	  females	  of	  55%	  and	  of	  54%	  
respectively	  in	  the	  subjects	  with	  and	  without	  childhood	  trauma,	  p<0.05).	  
Blood	   samples	  were	   collected	   by	   using	   PaxGene	  Blood	   Tubes.	   After	   collection,	   blood	   samples	  
were	  then	  kept	  at	  room	  temperature	  for	  2	  hours,	  then	  at	  -­‐20°C	  for	  2	  days	  and	  then	  at	  -­‐80°C	  until	  
their	  processing.	  	  
miRNA	  isolation	  from	  the	  blood	  of	  subjects	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Total	  RNA	  was	  extracted	  from	  2.5	  mL	  of	  blood	  with	  the	  PAXGene	  Blood	  miRNA	  Kit	  (QIAGEN,	  CA,	  
USA),	  designed	  for	  the	  simultaneous	   isolation	  of	  small	  and	  large	  RNAs;	  RNA	  concentration	  and	  
quality	  were	  assessed	  through	  a	  NanoDrop	  spectrophotometer	  (Thermo	  Scientific,	  MA,	  USA).	  
Real-­‐time	  PCR	  analyses	  
We	  looked	  specifically	  at	  the	  expression	  of	  hsa-­‐miR-­‐15a-­‐5p	  by	  Real	  Time	  PCR	  (RT-­‐PCR).	  RT-­‐PCR	  
was	   conducted	   using	   TaqMan	  MicroRNA	   Assays	   (Applied	   Biosystems,	   CA,	   USA),	   following	   the	  
manufacturer's	  instructions	  and	  the	  reactions	  were	  run	  on	  the	  StepOnePlus	  instrument	  (Applied	  
Biosystems, Waltham,	  MA).	  The	  Ct	  values	  were	  normalized	  according	  to	  the	  deltaCt	  	  method	  on	  
the	  endogenous	  controls	  RNU44	  and	  RNU48.	  
	  
